{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:41:47Z","timestamp":1790264507829,"version":"4.1.0"},"reference-count":34,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,3,30]]},"DOI":"10.3233\/jad-150899","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T17:14:16Z","timestamp":1459444456000},"page":"827-835","source":"Crossref","is-referenced-by-count":18,"title":["White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"51","author":[{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"first","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Cl\u00ednic, Barcelona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma C.","family":"Mont\u00e9","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Sala-Llonch","sequence":"additional","affiliation":[{"name":"Research Group for Lifespan Changes in Brain and Cognition (LCBC), Department of Psychology, University of Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bosch","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Cl\u00ednic, Barcelona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[{"name":"Memory Unit, Department of Neurology, Hospital de Sant Pau, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Llad\u00f3","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Cl\u00ednic, Barcelona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Antonell","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Cl\u00ednic, Barcelona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea","family":"Balasa","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Cl\u00ednic, Barcelona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Bargall\u00f3","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"},{"name":"Department of Radiology, Hospital Cl\u00ednic, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Cl\u00ednic, Barcelona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Biom\u00e8dica August Pi i Sunyer (IDIBAPS), Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-150899_ref1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-150899_ref2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","article-title":"Can we prevent Alzheimer\u2019s disease? Secondary \u201cprevention\u201d trials in Alzheimer\u2019s disease","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150899_ref3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neurol.2013.07.017","article-title":"Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial","volume":"169","author":"Mills","year":"2013","journal-title":"Rev Neurol (Paris)"},{"key":"10.3233\/JAD-150899_ref4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3233\/JAD-2011-0059","article-title":"Alzheimer\u2019s Prevention Initiative: A plan to accelerate the evaluation of presymptomatic treatments","volume":"26","author":"Reiman","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150899_ref5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.neurobiolaging.2011.09.005","article-title":"Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: An overview","volume":"32","author":"Morris","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150899_ref6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/alzrt213","article-title":"Dominantly Inherited Alzheimer Network: Facilitating research and clinical trials","volume":"17","author":"Moulder","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-150899_ref7","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","article-title":"The Alzheimer\u2019s Disease Neuroimaging Initiative: A review of papers published since its inception","volume":"9","author":"Weiner","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150899_ref8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-150899_ref9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","article-title":"Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer\u2019s disease in the presenilin 1 E280A kindred: A case-control study","volume":"11","author":"Reiman","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150899_ref10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1474-4422(06)70550-6","article-title":"Tracking atrophy progression in familial Alzheimer\u2019s disease: A serial MRI study","volume":"5","author":"Ridha","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-150899_ref11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/01.WNL.0000159743.08996.99","article-title":"Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease","volume":"64","author":"Fox","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-150899_ref12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3233\/JAD-2010-100678","article-title":"Increased cortical thickness and caudate volume precede atrophy inmutation carriers","volume":"22","author":"Fortea","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-150899_ref13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.neurobiolaging.2014.12.022","article-title":"Evolving brain structural changes inmutation carriers","volume":"36","author":"Sala-Llonch","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150899_ref14","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","article-title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease","volume":"110","author":"Benzinger","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-150899_ref15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jamaneurol.2015.1099","article-title":"Brain imaging and blood biomarker abnormalities in children with autosomal dominant Alzheimer disease: A cross-sectional study","volume":"72","author":"Quiroz","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-150899_ref16","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/brain\/awq203","article-title":"Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer\u2019s disease","volume":"133","author":"Villain","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JAD-150899_ref17","first-page":"187","article-title":"Subjects harboring presenilin familial Alzheimer\u2019s disease mutations exhibit diverse white matter biochemistry alterations","volume":"18","author":"Roher","year":"2013","journal-title":"Am J Neurodegener Dis"},{"key":"10.3233\/JAD-150899_ref18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-150899_ref19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/brain\/awp257","article-title":"Absolute diffusivities define the landscape of white matter degeneration in Alzheimer\u2019s disease","volume":"133","author":"Acosta-Cabronero","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JAD-150899_ref20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nicl.2013.07.006","article-title":"Effectiveness of regional DTI measures in distinguishing Alzheimer\u2019s disease, MCI, and normal aging","volume":"3","author":"Nir","year":"2013","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-150899_ref21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s11547-008-0286-1","article-title":"Evaluation of white matter damage in patients with Alzheimer\u2019s disease and in patients with mild cognitive impairment by using diffusion tensor imaging","volume":"113","author":"Ukmar","year":"2008","journal-title":"Radiol Med"},{"key":"10.3233\/JAD-150899_ref22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuroimage.2009.01.054","article-title":"Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer\u2019s disease","volume":"46","author":"Mielke","year":"2009","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150899_ref23","doi-asserted-by":"crossref","unstructured":"Acosta-Cabronero J , Alley S , Williams GB , Pengas G , Nestor PJ (2012) Diffusion tensor metrics as biomarkers in Alzheimer\u2019s disease. PLoS One 7, e49072.","DOI":"10.1371\/journal.pone.0049072"},{"key":"10.3233\/JAD-150899_ref24","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.neurobiolaging.2014.05.027","article-title":"White matter changes in preclinical Alzheimer\u2019s disease: A magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid \u03b2 protein 42 levels","volume":"35","author":"Molinuevo","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150899_ref25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-150899_ref26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1361-8415(01)00036-6","article-title":"A global optimisation method for robust affine registration of brain images","volume":"5","author":"Jenkinson","year":"2001","journal-title":"Med Image Anal"},{"key":"10.3233\/JAD-150899_ref27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0b013e3182a841c6","article-title":"The pattern of atrophy in familial Alzheimer disease: Volumetric MRI results from the DIAN study","volume":"15","author":"Cash","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-150899_ref28","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/awm102","article-title":"Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer\u2019s disease mutations","volume":"130","author":"Ringman","year":"2007","journal-title":"Brain"},{"key":"10.3233\/JAD-150899_ref29","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awv048","article-title":"Memory binding and white matter integrity in familial Alzheimer\u2019s disease","volume":"138","author":"Parra","year":"2015","journal-title":"Brain"},{"key":"10.3233\/JAD-150899_ref30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/joim.12352","article-title":"White matter changes in familial Alzheimer\u2019s disease","volume":"278","author":"Li","year":"2015","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-150899_ref31","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.neurobiolaging.2015.08.026","article-title":"Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer\u2019s disease","volume":"36","author":"Ryan","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-150899_ref32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1212\/WNL.48.4.1118","article-title":"A presenilin-1 mutation in a Japanese family with Alzheimer\u2019s disease and distinctive abnormalities on cranial MRI","volume":"48","author":"Aoki","year":"1997","journal-title":"Neurology"},{"key":"10.3233\/JAD-150899_ref33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/WNL.59.7.1108","article-title":"Presenilin-1 mutation (E280G), spastic paraparesis, and cranial MRI white-matter abnormalities","volume":"59","author":"O\u2019Riordan","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-150899_ref34","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/jnen\/60.12.1137","article-title":"Ectopic white matter neurons, a developmental abnormality that may be caused by the PSEN1 S169L mutation in a case of familial AD with myoclonus and seizures","volume":"60","author":"Takao","year":"2001","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-150899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:24Z","timestamp":1777370544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-150899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":34,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-150899","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]}}}